VHCP Management II, LLC

13F Portfolio Filings

  • Most recent 13F
    Q4 2019
  • Location
    new york, NY
  • CIK
    0001602263
  • All SEC filings
Q4 2019
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

20

$379.35M
TXG, AXSM, CNST, BIOHAVEN PHARMACTL HLDG CO L
13F-HR
Feb 13, 2020
000095012320001878

21

$262.41M
TXG, BIOHAVEN PHARMACTL HLDG CO L, ASND, SWAV
13F-HR
Nov 13, 2019
000095012319010839

21

$317.19M
ASND, SWAV, BIOHAVEN PHARMACTL HLDG CO L, OBSEVA SA
13F-HR
Aug 13, 2019
000095012319007806

21

$341.75M
ASND, BIOHAVEN PHARMACTL HLDG CO L, TRICIDA INC, SWAV
13F-HR
May 14, 2019
000095012319004909

19

$232.95M
BIOHAVEN PHARMACTL HLDG CO L, ASND, OBSEVA SA, BCRX
13F-HR
Feb 13, 2019
000095012319001657

21

$374.47M
ECYT, BIOHAVEN PHARMACTL HLDG CO L, OBSEVA SA, ASND
13F-HR
Nov 13, 2018
000095012318011328

18

$334.08M
ECYT, BIOHAVEN PHARMACTL HLDG CO L, OBSEVA SA, ASND
13F-HR
Aug 13, 2018
000095012318008382

17

$414.40M
AVXS, ECYT, ASND, BIOHAVEN PHARMACTL HLDG CO L
13F-HR
May 14, 2018
000095012318005292

18

$417.19M
AVXS, BIOHAVEN PHARMACTL HLDG CO L, ASND, ARGX
13F-HR
Feb 13, 2018
000095012318001778

21

$361.94M
AVXS, BIOHAVEN PHARMACTL HLDG CO L, ASND, ZGNX
13F-HR
Nov 13, 2017
000095012317010386

19

$250.38M
AVXS, BIOHAVEN PHARMACTL HLDG CO L, ASND, EDGE THERAPEUTICS INC
13F-HR
Aug 11, 2017
000095012317007498

20

$244.42M
AVXS, BCRX, ASND, DBV Technologies
13F-HR
May 12, 2017
000095012317004811

22

$208.50M
AVXS, BCRX, EDGE THERAPEUTICS INC, DBV Technologies
13F-HR
Feb 13, 2017
000095012317001786

24

$194.83M
AVXS, BCRX, EDGE THERAPEUTICS INC, DBV Technologies
13F-HR
Nov 14, 2016
000095012316022460

23

$165.69M
AVXS, EDGE THERAPEUTICS INC, DBV Technologies, BCRX
13F-HR
Aug 12, 2016
000095012316019771

22

$152.01M
AVXS, EDGE THERAPEUTICS INC, ASND, BCRX
13F-HR
May 13, 2016
000095012316017148

15

$121.74M
EDGE THERAPEUTICS INC, RGNX, DBV Technologies, ASND
13F-HR
Feb 12, 2016
000095012316014521
Vhcp Management Ii, Llc 13F Filings